Hims & Hers Health, Inc. (HIMS) financial statements (2022 and earlier)

Company profile

Business Address 2269 CHESTNUT ST
SAN FRANCISCO, CA 94123
State of Incorp. DE
Fiscal Year End December 31
SIC 8011 - Offices and Clinics of Doctors of Medicine (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments247,274252,425317,323323,2661,0581,2581,386
Cash and cash equivalents71,78464,772107,14588,1691,0581,2581,386
Short-term investments175,490187,653210,178235,097   
Receivables4,100      
Inventory, net of allowances, customer advances and progress billings13,55810,8586,5904,523   
Inventory13,55810,8586,5904,523   
Prepaid expense4,6068,9109,8568,650507590
Other current assets890716215   
Other undisclosed current assets(523)1,3242,5523,752   
Total current assets:269,905274,233336,342340,1961,1081,3331,476
Noncurrent Assets
Operating lease, right-of-use asset5,111      
Intangible assets, net (including goodwill)136,771137,8132,739    
Goodwill110,881110,8812,739    
Intangible assets, net (excluding goodwill)25,89026,932     
Assets held-in-trust    204,525204,481204,725
Restricted cash and investments856856856856   
Other noncurrent assets7,9427,1677,7624,848   
Total noncurrent assets:150,680145,83611,3575,704204,525204,481204,725
TOTAL ASSETS:420,585420,069347,699345,900205,633205,814206,201
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,83427,30026,32519,0564,2382,604558
Accounts payable19,64016,09415,56413,233482522
Accrued liabilities12,19411,20610,7615,8234,1902,579536
Deferred revenue3,1881,9931,019624   
Due to related parties    599404495
Business combination, contingent consideration, liability42,83423,205     
Other undisclosed current liabilities1,365   6030115
Total current liabilities:79,22152,49827,34419,6804,8973,0381,168
Noncurrent Liabilities
Long-term debt and lease obligation4,117      
Operating lease, liability4,117      
Liabilities, other than long-term debt2,62812,4181,895384   
Deferred rent credit   384   
Other liabilities6291,2181,895    
Business combination, contingent consideration, liability1,99911,200     
Other undisclosed noncurrent liabilities  25,40633,3707,1947,1947,194
Total noncurrent liabilities:6,74512,41827,30133,7547,1947,1947,194
Total liabilities:85,96664,91654,64553,43412,09010,2318,361
Temporary equity, carrying amount    188,543190,583192,839
Stockholders' equity
Stockholders' equity attributable to parent, including:334,619355,153293,054292,4665,0005,0005,000
Common stock20201918   
Additional paid in capital613,687602,975524,924515,2166,9014,8622,605
Accumulated other comprehensive loss(137)(52)(40)(72)   
Retained earnings (accumulated deficit)(278,951)(247,790)(231,849)(222,696)(1,902)1382,395
Other undisclosed stockholders' equity attributable to parent    111
Total stockholders' equity:334,619355,153293,054292,4665,0005,0005,000
TOTAL LIABILITIES AND EQUITY:420,585420,069347,699345,900205,633205,814206,201

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues84,69974,17360,69252,314   
Cost of revenue(22,601)(19,301)(13,415)(12,067)   
Gross profit:62,09854,87247,27740,247   
Operating expenses(83,663)(82,533)(64,684)(88,656)(2,083)(2,338)(124)
Operating loss:(21,565)(27,661)(17,407)(48,409)(2,083)(2,338)(124)
Nonoperating income (expense)(9,683)8,5478,288(2,905)448137
Investment income, nonoperating      37
Interest and debt expense   (144)   
Loss from continuing operations before equity method investments, income taxes:(31,248)(19,114)(9,119)(51,458)(2,039)(2,257)(87)
Other undisclosed income from continuing operations before income taxes   144   
Loss from continuing operations before income taxes:(31,248)(19,114)(9,119)(51,314)(2,039)(2,257)(87)
Income tax expense (benefit)873,173(34)(90)   
Net loss available to common stockholders, diluted:(31,161)(15,941)(9,153)(51,404)(2,039)(2,257)(87)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(31,161)(15,941)(9,153)(51,404)(2,039)(2,257)(87)
Comprehensive loss:(31,161)(15,941)(9,153)(51,404)(2,039)(2,257)(87)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(85)(12)32(61)   
Comprehensive loss, net of tax, attributable to parent:(31,246)(15,953)(9,121)(51,465)(2,039)(2,257)(87)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: